PMID- 23404999 OWN - NLM STAT- MEDLINE DCOM- 20131114 LR - 20211021 IS - 1755-3245 (Electronic) IS - 0008-6363 (Print) IS - 0008-6363 (Linking) VI - 98 IP - 2 DP - 2013 May 1 TI - Cardiomyocyte ryanodine receptor degradation by chaperone-mediated autophagy. PG - 277-85 LID - 10.1093/cvr/cvt029 [doi] AB - AIMS: Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ. These proteins are targeted by chaperones and delivered to lysosomes where they are translocated into the lysosomal lumen and degraded via the lysosome-associated membrane protein type 2A (LAMP-2A). Mutations in LAMP2 that inhibit autophagy result in Danon disease characterized by hypertrophic cardiomyopathy. The ryanodine receptor type 2 (RyR2) plays a key role in cardiomyocyte excitation-contraction and its dysfunction can lead to cardiac failure. Whether RyR2 is degraded by CMA is unknown. METHODS AND RESULTS: To induce CMA, cultured neonatal rat cardiomyocytes were treated with geldanamycin (GA) to promote protein degradation through this pathway. GA increased LAMP-2A levels together with its redistribution and colocalization with Hsc70 in the perinuclear region, changes indicative of CMA activation. The inhibition of lysosomes but not proteasomes prevented the loss of RyR2. The recovery of RyR2 content after incubation with GA by siRNA targeting LAMP-2A suggests that RyR2 is degraded via CMA. In silico analysis also revealed that the RyR2 sequence harbours six KFERQ motifs which are required for the recognition Hsc70 and its degradation via CMA. Our data suggest that presenilins are involved in RyR2 degradation by CMA. CONCLUSION: These findings are consistent with a model in which oxidative damage of the RyR2 targets it for turnover by presenilins and CMA, which could lead to removal of damaged or leaky RyR2 channels. FAU - Pedrozo, Zully AU - Pedrozo Z AD - Centro de Estudios Moleculares de la Celula, Facultad de Ciencias Quimicas y Farmaceuticas & Facultad de Medicina, Universidad de Chile, Santiago 8380492, Chile. zpedrozo@med.uchile.cl FAU - Torrealba, Natalia AU - Torrealba N FAU - Fernandez, Carolina AU - Fernandez C FAU - Gatica, Damian AU - Gatica D FAU - Toro, Barbra AU - Toro B FAU - Quiroga, Clara AU - Quiroga C FAU - Rodriguez, Andrea E AU - Rodriguez AE FAU - Sanchez, Gina AU - Sanchez G FAU - Gillette, Thomas G AU - Gillette TG FAU - Hill, Joseph A AU - Hill JA FAU - Donoso, Paulina AU - Donoso P FAU - Lavandero, Sergio AU - Lavandero S LA - eng GR - R01 HL120732/HL/NHLBI NIH HHS/United States GR - HL-075173/HL/NHLBI NIH HHS/United States GR - HL-080144/HL/NHLBI NIH HHS/United States GR - HL-090842/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130211 PL - England TA - Cardiovasc Res JT - Cardiovascular research JID - 0077427 RN - 0 (Benzoquinones) RN - 0 (Lactams, Macrocyclic) RN - 0 (Molecular Chaperones) RN - 0 (Presenilins) RN - 0 (Ryanodine Receptor Calcium Release Channel) RN - EC 3.4.25.1 (Proteasome Endopeptidase Complex) RN - Z3K3VJ16KU (geldanamycin) SB - IM MH - Amino Acid Sequence MH - Animals MH - *Autophagy MH - Benzoquinones/pharmacology MH - Lactams, Macrocyclic/pharmacology MH - Lysosomes/metabolism MH - Molecular Chaperones/*physiology MH - Molecular Sequence Data MH - Myocardial Ischemia/metabolism MH - Myocytes, Cardiac/*metabolism MH - Oxidative Stress MH - Presenilins/physiology MH - Proteasome Endopeptidase Complex/physiology MH - Rats MH - Rats, Sprague-Dawley MH - Ryanodine Receptor Calcium Release Channel/chemistry/*metabolism PMC - PMC3633160 EDAT- 2013/02/14 06:00 MHDA- 2013/11/15 06:00 PMCR- 2014/05/01 CRDT- 2013/02/14 06:00 PHST- 2013/02/14 06:00 [entrez] PHST- 2013/02/14 06:00 [pubmed] PHST- 2013/11/15 06:00 [medline] PHST- 2014/05/01 00:00 [pmc-release] AID - cvt029 [pii] AID - 10.1093/cvr/cvt029 [doi] PST - ppublish SO - Cardiovasc Res. 2013 May 1;98(2):277-85. doi: 10.1093/cvr/cvt029. Epub 2013 Feb 11.